Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Cell International|May 6, 2014
Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cellsAaron L Miller, Chuandong Geng, Georgiy Golovko, et al.
Molecular Endocrinology (Baltimore, Md.)|June 13, 2015
miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell ProliferationVijay Kumar Eedunuri, Kimal Rajapakshe, Warren Fiskus, et al.
Cancer Research|October 3, 2014
Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancerChuandong Geng, Kimal Rajapakshe, Shrijal S Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate CancerZhe Tang, Patrick G Pilié, Chuandong Geng, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2013
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnoverChuandong Geng, Bin He, Limei Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate CancerBo Liu, Likun Li, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Molecular Cancer Therapeutics|June 23, 2021
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate CancerCheng Wu, Shan Peng, Patrick G Pilié, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 2014
GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complexBin He, Rainer B Lanz, Warren Fiskus, et al.
Pageof 1